Thus, the aim of this research work was to unravel the potential effects of gut peptide hormones on human AT by characterizing the effects of GLP-1, GIP and glucagon on VAT exometabolomic profiles pertaining to individuals with obesity across different glycemic statuses. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.